Syneron Medical Ltd (ELOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2016 | 12-2015 | 12-2014 | 12-2013 | 12-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 56,756 | 56,330 | 57,189 | 37,580 | 66,350 |
| Marketable Securities | 11,143 | 14,631 | 36,469 | 45,380 | 61,650 |
| Receivables | 69,924 | 65,861 | 63,132 | 54,220 | 50,020 |
| Inventories | 47,376 | 49,352 | 36,894 | 34,700 | 36,860 |
| Other current assets | 0 | 0 | 0 | 14,280 | 12,580 |
| TOTAL | $185,199 | $186,174 | $193,684 | $186,160 | $227,460 |
| Non-Current Assets | |||||
| PPE Net | 12,529 | 9,823 | 7,011 | 6,600 | 6,140 |
| Investments And Advances | 34,564 | 35,787 | 37,182 | 50,290 | 8,960 |
| Intangibles | 26,774 | 34,136 | 46,983 | 0 | 0 |
| Other Non-Current Assets | 18,119 | 20,872 | 21,974 | 62,400 | 76,510 |
| TOTAL | $91,986 | $100,618 | $113,150 | $119,290 | $91,610 |
| Total Assets | $277,185 | $286,792 | $306,834 | $305,470 | $319,090 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 51,635 | 59,361 | 54,543 | 17,670 | 19,920 |
| Other current liabilities | N/A | N/A | N/A | 40,830 | 61,870 |
| TOTAL | $64,473 | $71,842 | $68,597 | $58,510 | $81,800 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 12,838 | 12,481 | 14,054 | N/A | N/A |
| Other Non-Current Liabilities | 2,353 | 2,342 | 6,350 | 9,380 | 8,140 |
| TOTAL | $5,292 | $5,737 | $10,272 | $15,170 | $15,150 |
| Total Liabilities | $69,765 | $77,579 | $78,869 | $73,680 | $96,960 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | N/A | N/A | 36,748 | 36,631 | 35,609 |
| Common Shares | 91 | 91 | 90 | 80 | 80 |
| Retained earnings | 43,473 | 43,294 | 49,634 | 54,830 | 53,180 |
| Other shareholders' equity | -7,815 | -7,220 | -4,907 | -1,050 | 1,390 |
| TOTAL | $207,420 | $209,213 | $227,965 | $231,780 | $222,120 |
| Total Liabilities And Equity | $277,185 | $286,792 | $306,834 | $305,460 | $319,080 |